AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
RNA drug developer ADARx seeks $1.74 billion valuation in US IPO - Reuters

RNA drug developer ADARx seeks $1.74 billion valuation in US IPO - Reuters

RNA drug developer ADARx seeks $1.74 billion valuation in US IPO Reuters

September 21, 2026 at 11:43 AM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

Locations

United States

Tags

adarx drug developer ipo rna valuation

All Coverage

RNA drug developer ADARx seeks $1.74 billion valuation in US IPO - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxOUDdGZzVQcUgxaHgwWVV5Z1h2Z3NrdFZYYjVNdnhxX0tzb0NKUEs0RXZVeEdCMHEybkJvRWNpWllYWEtzcmhlQXVwQzB5MzJfUGppNkR3Snd6cXF6MXk4aUEwQ3JHWlBQY1NTRm9YVmVHeFdQdVF0RmdQNG5tbWZyb1J2cUVFVklrNVVTUmxKWjQxcncxalQyR0ExX0FwQW45S1dZX2FSazhXbnBxaWVHRVlqd3FLYzVWSVYxRHFnZGpWcXBOb1pHYnRR?oc=5" target="_blank">RNA drug developer ADARx seeks $1.74 billion valuation in US IPO</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%

Similar Stories

Related coverage based on topic and tags

ADARx Pharmaceuticals shares soar in Nasdaq debut after upsized IPO - Reuters

ADARx Pharmaceuticals shares soar in Nasdaq debut after upsized IPO Reuters

September 25, 2026 at 05:27 PM

AI-based drug developer Basecamp valued at $800 million after $140 million funding round - Reuters

AI-based drug developer Basecamp valued at $800 million after $140 million funding round Reuters

September 23, 2026 at 01:08 PM

Oura targets $15.62 billion valuation in US IPO, setting stage for fall listings - reuters.com

Oura targets $15.62 billion valuation in US IPO, setting stage for fall listings reuters.com

September 21, 2026 at 12:07 PM

Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on - Reuters

Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on Reuters

September 21, 2026 at 10:32 PM

China's InnoCare, Eli Lilly sign collaboration deal worth up to $3.35 billion - Reuters

China's InnoCare, Eli Lilly sign collaboration deal worth up to $3.35 billion Reuters

September 24, 2026 at 04:55 AM

Four Chinese firms seek to raise up to $1.83 billion in Hong Kong offerings - Reuters

Four Chinese firms seek to raise up to $1.83 billion in Hong Kong offerings Reuters

September 20, 2026 at 10:26 PM